Latest Financial Performance News

Little Green Pharma Ltd reported a 9.6% revenue increase to $19.2 million and slashed its net loss by 73% in the half-year ending September 2025, driven by strong growth in European medicinal cannabis markets.

Nationwide Building Society reports a solid first half of 2025 with underlying profit before tax rising to £977 million, driven by strong mortgage and deposit growth following its acquisition of Virgin Money. The Group maintains robust capital and credit quality while delivering significant value to members.

Oceania Healthcare reports a robust interim result for the six months to September 2025, with significant earnings growth, improved sales, and a reduction in debt gearing. The company’s strategic focus on cost control, capital management, and sustainable care delivery underpins its positive outlook despite housing market headwinds.

Oceania Healthcare has posted a strong half-year turnaround with improved sales, cost savings, and reduced gearing, setting the stage for renewed growth and operational strength.

EROAD Limited reported a 3.3% revenue increase and strong free cash flow in H1 FY26, driven by ANZ market expansion despite a significant North American impairment. The company is focusing on the promising electronic Road User Charges opportunity in Australasia.

Janus Electric Holdings will have its trading suspension lifted on 21 November 2025 following the release of its annual financial report, reopening the stock to market activity.

Monash IVF Group reported a 6.7% revenue increase to $271.9 million for FY25, alongside an 8.1% decline in underlying NPAT, aligning with prior guidance. The company outlined a cautious FY26 outlook focused on innovation, doctor retention, and cost management.

Monash IVF Group reported solid FY25 revenue and EBITDA growth despite sector softness and clinical incidents, while announcing a leadership transition and dividend pause.

Charter Hall Group reported solid FY25 financial results with significant earnings growth and sustainability milestones, while guiding higher earnings and distributions for FY26.

GenusPlus Group has reported a landmark FY2025 with record revenue and profits, driven by strong growth in renewable energy infrastructure and transmission projects. The company’s robust orderbook and strategic acquisitions set the stage for continued expansion in FY2026.

Bubs Australia Limited reported a solid FY25 with $102.5 million revenue and outlined ambitious FY26 guidance targeting up to $125 million, driven by overseas markets and strategic investments.

SKS Technologies reported a remarkable doubling of profit in FY25, driven by strong organic growth and a strategic acquisition that positions it for rapid expansion in Australia's largest data centre market.